Yongan Pharmaceutical
SZSE · 002365
Market Cap$3.4B
Revenue$847.9M
Employees912
Listed OnSZSE
Ticker002365
CEO / ExecMr. Rengui Hong
HeadquartersQianjiang
MarketMainland China
Websitewww.chinataurine.com
Overview
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.